MENTHOL AND METHYL SALICYLATE

MENTHOL AND METHYL SALICYLATE was reported 689 times

These side effects are most commonly reported by patients taking MENTHOL AND METHYL SALICYLATE:

# Side effect Count
0 DRUG INEFFECTIVE 178
1 NO ADVERSE EVENT 120
2 APPLICATION SITE BURN 57
3 PAIN 44
4 APPLICATION SITE PAIN 40
5 BLISTER 33
6 BURNING SENSATION 28
7 APPLICATION SITE ERYTHEMA 24
8 SKIN BURNING SENSATION 24
9 ARTHRALGIA 23
10 APPLICATION SITE VESICLES 22
11 PAIN IN EXTREMITY 21
12 THERMAL BURN 21
13 BURNS SECOND DEGREE 20
14 ERYTHEMA 20
15 FATIGUE 19
16 HEADACHE 19
17 NAUSEA 19
18 CHEMICAL INJURY 18
19 DYSPNOEA 18
20 DIARRHOEA 17
21 PRURITUS 16
22 BACK PAIN 15
23 SKIN EXFOLIATION 14
24 VOMITING 14
25 CHEMICAL BURN 13
26 DIZZINESS 13
27 HYPERSENSITIVITY 13
28 INSOMNIA 13
29 FALL 12
30 PERIPHERAL SWELLING 12
31 MUSCLE SPASMS 11
32 PRODUCT ADMINISTERED AT INAPPROPRIATE SITE 11
33 PRODUCT USE ISSUE 11
34 SCAR 11
35 CONSTIPATION 10
36 GAIT DISTURBANCE 10
37 HYPOAESTHESIA 10
38 INFUSION SITE PAIN 10
39 LOSS OF CONSCIOUSNESS 10
40 NECK PAIN 10
41 PRODUCT QUALITY ISSUE 10
42 RASH 10
43 SCAB 10
44 SKIN DISCOLOURATION 9
45 URINARY TRACT INFECTION 9
46 ARTHRITIS 8
47 BURNS THIRD DEGREE 8
48 DECREASED APPETITE 8
49 MALAISE 8
50 OFF LABEL USE 8
51 PYREXIA 8
52 ABDOMINAL PAIN 7
53 ASTHENIA 7
54 DEATH 7
55 FEELING ABNORMAL 7
56 SWELLING 7
57 WEIGHT INCREASED 7
58 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 6
59 HYPOTENSION 6
60 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 6
61 INFECTION 6
62 INFUSION SITE ERYTHEMA 6
63 MUSCULOSKELETAL PAIN 6
64 MYALGIA 6
65 PNEUMONIA 6
66 SOMNOLENCE 6
67 ABDOMINAL DISCOMFORT 5
68 ANAPHYLACTIC REACTION 5
69 APPLICATION SITE DISCOLOURATION 5
70 BLOOD PRESSURE DECREASED 5
71 CHEMICAL BURN OF SKIN 5
72 CONDITION AGGRAVATED 5
73 CONTUSION 5
74 DISCOMFORT 5
75 EXPIRED PRODUCT ADMINISTERED 5
76 FEELING HOT 5
77 HYPERAESTHESIA 5
78 LIMB DISCOMFORT 5
79 OEDEMA PERIPHERAL 5
80 PRODUCT USE IN UNAPPROVED INDICATION 5
81 SKIN DISORDER 5
82 SKIN IRRITATION 5
83 URTICARIA 5
84 AMNESIA 4
85 ANXIETY 4
86 APPLICATION SITE EXFOLIATION 4
87 APPLICATION SITE PRURITUS 4
88 APPLICATION SITE REACTION 4
89 APPLICATION SITE SWELLING 4
90 BLOOD PRESSURE INCREASED 4
91 BRONCHITIS 4
92 COUGH 4
93 COVID-19 4
94 DEPRESSION 4
95 DEVICE ISSUE 4
96 DYSPHONIA 4
97 EYE PAIN 4
98 INFUSION SITE HAEMORRHAGE 4
99 INFUSION SITE PRURITUS 4
100 INFUSION SITE SWELLING 4
101 INJURY 4
102 JOINT SWELLING 4
103 MOBILITY DECREASED 4
104 MUSCULOSKELETAL STIFFNESS 4
105 NASAL CONGESTION 4
106 NASOPHARYNGITIS 4
107 NERVE INJURY 4
108 NEUROPATHY PERIPHERAL 4
109 PAIN OF SKIN 4
110 PARAESTHESIA 4
111 PRODUCT ADHESION ISSUE 4
112 PSORIASIS 4
113 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 4
114 WOUND SECRETION 4
115 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 4
116 APPLICATION SITE IRRITATION 3
117 APPLICATION SITE SCAR 3
118 ASTHMA 3
119 BONE PAIN 3
120 BURN INFECTION 3
121 CARDIAC DISORDER 3
122 CHEST DISCOMFORT 3
123 CHEST PAIN 3
124 CHILLS 3
125 DEEP VEIN THROMBOSIS 3
126 DEPRESSED MOOD 3
127 DEVICE OCCLUSION 3
128 DRUG ADMINISTERED AT INAPPROPRIATE SITE 3
129 DRUG DEPENDENCE 3
130 DRUG EFFECT LESS THAN EXPECTED 3
131 DYSGEUSIA 3
132 EYE SWELLING 3
133 FLUID RETENTION 3
134 HEAD INJURY 3
135 ILLNESS 3
136 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 3
137 INCORRECT DRUG ADMINISTRATION DURATION 3
138 INJECTION SITE BRUISING 3
139 INJECTION SITE HAEMORRHAGE 3
140 INJECTION SITE PAIN 3
141 INTENTIONAL PRODUCT MISUSE 3
142 JOINT STIFFNESS 3
143 MEMORY IMPAIRMENT 3
144 MUSCULAR WEAKNESS 3
145 MUSCULOSKELETAL DISCOMFORT 3
146 MYOCARDIAL INFARCTION 3
147 MYOSITIS 3
148 NEOPLASM MALIGNANT 3
149 PRODUCT ODOUR ABNORMAL 3
150 PRODUCTIVE COUGH 3
151 RHEUMATOID ARTHRITIS 3
152 ROAD TRAFFIC ACCIDENT 3
153 SEPSIS 3
154 THERAPEUTIC RESPONSE DECREASED 3
155 TREMOR 3
156 VISION BLURRED 3
157 WEIGHT DECREASED 3
158 WRONG TECHNIQUE IN DRUG USAGE PROCESS 3
159 ABDOMINAL PAIN UPPER 2
160 ACCIDENT 2
161 ACCIDENTAL EXPOSURE TO PRODUCT 2
162 ACTIVITIES OF DAILY LIVING IMPAIRED 2
163 ADVERSE DRUG REACTION 2
164 ADVERSE EVENT 2
165 ALOPECIA 2
166 APPLICATION SITE BRUISE 2
167 APPLICATION SITE HYPERSENSITIVITY 2
168 APPLICATION SITE RASH 2
169 APPLICATION SITE SCAB 2
170 ARTHROPATHY 2
171 ASPIRATION 2
172 BACK DISORDER 2
173 BACK INJURY 2
174 BACTERIAL TEST POSITIVE 2
175 BLOOD PRESSURE ABNORMAL 2
176 BURNS FIRST DEGREE 2
177 CANDIDA INFECTION 2
178 CARDIAC FAILURE CONGESTIVE 2
179 CELLULITIS 2
180 CHOKING 2
181 CHONDROPATHY 2
182 CHRONIC KIDNEY DISEASE 2
183 CONFUSIONAL STATE 2
184 DEVICE DISLOCATION 2
185 DEVICE MAINTENANCE ISSUE 2
186 DRUG DOSE OMISSION 2
187 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 2
188 DRUG INTERACTION 2
189 DRY MOUTH 2
190 FLATULENCE 2
191 FRUSTRATION TOLERANCE DECREASED 2
192 GASTRITIS EROSIVE 2
193 GINGIVITIS 2
194 HAEMOPTYSIS 2
195 HAEMORRHAGE 2
196 HEART RATE INCREASED 2
197 HERPES ZOSTER 2
198 HOSPITALISATION 2
199 HYPERTHYROIDISM 2
200 IMPAIRED HEALING 2
201 INCORRECT ROUTE OF DRUG ADMINISTRATION 2
202 INFLAMMATION 2
203 INFUSION SITE DISCOMFORT 2
204 INFUSION SITE INFLAMMATION 2
205 INFUSION SITE IRRITATION 2
206 INJECTION SITE ERYTHEMA 2
207 INSURANCE ISSUE 2
208 INTERNATIONAL NORMALISED RATIO DECREASED 2
209 JOINT EFFUSION 2
210 LIMB INJURY 2
211 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 2
212 LUNG DISORDER 2
213 MEDICATION ERROR 2
214 METASTASES TO BONE 2
215 MIGRAINE 2
216 MOVEMENT DISORDER 2
217 MUSCLE ATROPHY 2
218 MUSCLE STRAIN 2
219 NASAL OEDEMA 2
220 NEPHROPATHY 2
221 NEURALGIA 2
222 OEDEMA 2
223 ORTHOSTATIC HYPOTENSION 2
224 PALPITATIONS 2
225 PRODUCT DOSE OMISSION 2
226 PRODUCT DOSE OMISSION ISSUE 2
227 PRODUCT PHYSICAL ISSUE 2
228 PULMONARY EMBOLISM 2
229 RASH ERYTHEMATOUS 2
230 RASH PAPULAR 2
231 RENAL IMPAIRMENT 2
232 RHINORRHOEA 2
233 SEASONAL ALLERGY 2
234 SECOND DEGREE CHEMICAL BURN OF SKIN 2
235 SEIZURE 2
236 SINUSITIS 2
237 SKIN DEPIGMENTATION 2
238 SPEECH DISORDER 2
239 SUSPECTED PRODUCT QUALITY ISSUE 2
240 TACHYCARDIA 2
241 TENDERNESS 2
242 TERMINAL STATE 2
243 THERAPEUTIC PRODUCT EFFECT DECREASED 2
244 THERAPEUTIC RESPONSE UNEXPECTED 2
245 THERAPY CESSATION 2
246 THERAPY CHANGE 2
247 THERAPY NON-RESPONDER 2
248 TOOTH FRACTURE 2
249 TOXICITY TO VARIOUS AGENTS 2
250 UNDERDOSE 2
251 URINARY RETENTION 2
252 WOUND 2
253 WRONG PRODUCT ADMINISTERED 2
254 ABASIA 1
255 ABDOMINAL DISTENSION 1
256 ABNORMAL BEHAVIOUR 1
257 ACCIDENTAL EXPOSURE TO PRODUCT BY CHILD 1
258 ADMINISTRATION SITE PAIN 1
259 ADULT FAILURE TO THRIVE 1
260 ALLERGY TO PLANTS 1
261 ALVEOLAR OSTEITIS 1
262 ANKLE FRACTURE 1
263 APPLICATION SITE DRYNESS 1
264 APPLICATION SITE HAEMORRHAGE 1
265 APPLICATION SITE HYPOAESTHESIA 1
266 APPLICATION SITE INFECTION 1
267 APPLICATION SITE INFLAMMATION 1
268 APPLICATION SITE PUSTULES 1
269 APPLICATION SITE WARMTH 1
270 ASTHMATIC CRISIS 1
271 ATRIAL FIBRILLATION 1
272 ATRIOVENTRICULAR BLOCK 1
273 BACTERIAL ABDOMINAL INFECTION 1
274 BALANCE DISORDER 1
275 BASAL GANGLIA HAEMATOMA 1
276 BEDRIDDEN 1
277 BILE DUCT STONE 1
278 BLADDER ULCER 1
279 BLINDNESS TRANSIENT 1
280 BLOOD BLISTER 1
281 BLOOD COUNT ABNORMAL 1
282 BLOOD IRON INCREASED 1
283 BLOOD PHOSPHORUS DECREASED 1
284 BLOOD POTASSIUM DECREASED 1
285 BLOOD PRESSURE FLUCTUATION 1
286 BLOOD TRIGLYCERIDES INCREASED 1
287 BRADYCARDIA 1
288 BREAST SWELLING 1
289 BUNDLE BRANCH BLOCK RIGHT 1
290 BURNS FOURTH DEGREE 1
291 CARTILAGE INJURY 1
292 CATARACT 1
293 CEREBRAL ARTERIOSCLEROSIS 1
294 CEREBRAL HAEMORRHAGE 1
295 CEREBROVASCULAR ACCIDENT 1
296 CHEST X-RAY ABNORMAL 1
297 CHOLANGITIS 1
298 CHONDROLYSIS 1
299 CHROMATURIA 1
300 CIRCULATORY COLLAPSE 1
301 CLOSTRIDIUM DIFFICILE COLITIS 1
302 COAGULOPATHY 1
303 COGNITIVE DISORDER 1
304 COMPRESSION FRACTURE 1
305 CONCOMITANT DISEASE AGGRAVATED 1
306 CONJUNCTIVITIS 1
307 CRYING 1
308 CYANOSIS 1
309 CYSTITIS 1
310 CYSTITIS INTERSTITIAL 1
311 DEAFNESS 1
312 DECREASED ACTIVITY 1
313 DENTAL CARIES 1
314 DERMATITIS 1
315 DERMATITIS ACNEIFORM 1
316 DERMATITIS CONTACT 1
317 DEVICE ADHESION ISSUE 1
318 DEVICE ALARM ISSUE 1
319 DEVICE DIFFICULT TO USE 1
320 DEVICE FAILURE 1
321 DEVICE INFORMATION OUTPUT ISSUE 1
322 DEVICE INFUSION ISSUE 1
323 DEVICE POWER SOURCE ISSUE 1
324 DEVICE STIMULATION ISSUE 1
325 DISABILITY 1
326 DISEASE PROGRESSION 1
327 DISORIENTATION 1
328 DRUG EFFECT INCOMPLETE 1
329 DRUG HYPERSENSITIVITY 1
330 DRUG SCREEN NEGATIVE 1
331 DRUG TOLERANCE DECREASED 1
332 DRUG TOXICITY 1
333 DRUG WITHDRAWAL SYNDROME 1
334 DRY EYE 1
335 DRY SKIN 1
336 DUST ALLERGY 1
337 DYSPEPSIA 1
338 DYSPHAGIA 1
339 DYSPNOEA EXERTIONAL 1
340 DYSTONIA 1
341 EAR PAIN 1
342 ECONOMIC PROBLEM 1
343 ECZEMA 1
344 EMOTIONAL DISTRESS 1
345 ENTEROCOLITIS 1
346 ENURESIS 1
347 EPILEPSY 1
348 EPISTAXIS 1
349 ESCHAR 1
350 ESSENTIAL HYPERTENSION 1
351 EXPIRED DRUG ADMINISTERED 1
352 EXPOSURE DURING PREGNANCY 1
353 EYE DISORDER 1
354 EYE INFLAMMATION 1
355 FEELING OF BODY TEMPERATURE CHANGE 1
356 FINE MOTOR SKILL DYSFUNCTION 1
357 FINGER DEFORMITY 1
358 FROSTBITE 1
359 FRUSTRATION 1
360 GAIT INABILITY 1
361 GALLBLADDER DISORDER 1
362 GASTRIC ULCER 1
363 GASTROINTESTINAL DISORDER 1
364 GASTROOESOPHAGEAL REFLUX DISEASE 1
365 GENITAL BURNING SENSATION 1
366 GINGIVAL DISCOMFORT 1
367 GINGIVAL SWELLING 1
368 GLOMERULAR FILTRATION RATE INCREASED 1
369 GLOSSITIS 1
370 GLOSSODYNIA 1
371 HAEMARTHROSIS 1
372 HAEMATOCHEZIA 1
373 HAEMORRHAGE INTRACRANIAL 1
374 HAEMORRHAGIC ANAEMIA 1
375 HALLUCINATION 1
376 HEAD DISCOMFORT 1
377 HEMIPARESIS 1
378 HEPATOMEGALY 1
379 HIATUS HERNIA 1
380 HOT FLUSH 1
381 HYDROTHORAX 1
382 HYPERCALCAEMIA 1
383 HYPERHIDROSIS 1
384 HYPERKERATOSIS 1
385 HYPERSOMNIA 1
386 HYPERTENSIVE EMERGENCY 1
387 HYPERTRIGLYCERIDAEMIA 1
388 HYPERVIGILANCE 1
389 HYPERVOLAEMIA 1
390 HYPOACUSIS 1
391 HYPOKALAEMIA 1
392 HYPOTHERMIA 1
393 INABILITY TO AFFORD MEDICATION 1
394 INADEQUATE ANALGESIA 1
395 INCISION SITE HAEMORRHAGE 1
396 INCORRECT DOSE ADMINISTERED 1
397 INCORRECT PRODUCT ADMINISTRATION DURATION 1
398 INCREASED APPETITE 1
399 INFECTIVE PULMONARY EXACERBATION OF CYSTIC FIBROSIS 1
400 INFLUENZA A VIRUS TEST POSITIVE 1
401 INFLUENZA LIKE ILLNESS 1
402 INFUSION SITE INDURATION 1
403 INFUSION SITE OEDEMA 1
404 INFUSION SITE REACTION 1
405 INFUSION SITE WARMTH 1
406 INITIAL INSOMNIA 1
407 INJECTION SITE INDURATION 1
408 INJECTION SITE MASS 1
409 INJECTION SITE OEDEMA 1
410 INJECTION SITE SWELLING 1
411 INJECTION SITE URTICARIA 1
412 INTENTIONAL DOSE OMISSION 1
413 INTENTIONAL OVERDOSE 1
414 INTENTIONAL PRODUCT MISUSE TO CHILD 1
415 INTERVERTEBRAL DISC PROTRUSION 1
416 IRRITABILITY 1
417 JAUNDICE NEONATAL 1
418 JOINT NOISE 1
419 KELOID SCAR 1
420 KNEE DEFORMITY 1
421 LEG AMPUTATION 1
422 LETHARGY 1
423 LIMB CRUSHING INJURY 1
424 LIMB MASS 1
425 LIP SWELLING 1
426 LOCAL SWELLING 1
427 LOWER GASTROINTESTINAL HAEMORRHAGE 1
428 LOWER LIMB FRACTURE 1
429 LUMBAR SPINAL STENOSIS 1
430 LYMPHADENOPATHY 1
431 MALIGNANT NEOPLASM PROGRESSION 1
432 MASS 1
433 MASTOID EFFUSION 1
434 MATERNAL DRUGS AFFECTING FOETUS 1
435 MEDICAL DEVICE SITE PAIN 1
436 MIDDLE INSOMNIA 1
437 MOTOR DYSFUNCTION 1
438 MUCOSAL HYPERTROPHY 1
439 MULTI-ORGAN DISORDER 1
440 MULTIPLE INJURIES 1
441 MULTIPLE SCLEROSIS 1
442 MUSCLE DISORDER 1
443 MUSCLE HAEMORRHAGE 1
444 MUSCLE RIGIDITY 1
445 MUSCLE TIGHTNESS 1
446 MUSCULOSKELETAL CHEST PAIN 1
447 NECK SURGERY 1
448 NEGATIVISM 1
449 NEOPLASM 1
450 NEPHROLITHIASIS 1
451 NERVE COMPRESSION 1
452 NEUTROPHIL COUNT ABNORMAL 1
453 NIGHT SWEATS 1
454 NIPPLE SWELLING 1
455 NODULE 1
456 OCULAR HYPERAEMIA 1
457 OFF LABEL USE OF DEVICE 1
458 ORCHIDECTOMY 1
459 OROPHARYNGEAL PAIN 1
460 OSTEOMYELITIS 1
461 OSTEOPOROSIS 1
462 PAIN IN JAW 1
463 PANCREATIC MASS 1
464 PANCREATITIS 1
465 PANIC ATTACK 1
466 PANIC REACTION 1
467 PARANASAL SINUS HYPERSECRETION 1
468 PELVIC PAIN 1
469 PERICARDIAL EFFUSION 1
470 PERICARDITIS 1
471 PHARYNGEAL OEDEMA 1
472 PHARYNGITIS STREPTOCOCCAL 1
473 PLASMA CELL MYELOMA 1
474 PLATELET COUNT ABNORMAL 1
475 POISONING 1
476 POLLAKIURIA 1
477 POOR PERIPHERAL CIRCULATION 1
478 POOR QUALITY PRODUCT ADMINISTERED 1
479 POOR QUALITY SLEEP 1
480 POST PROCEDURAL COMPLICATION 1
481 POST PROCEDURAL INFECTION 1
482 POST-ACUTE COVID-19 SYNDROME 1
483 POST-TRAUMATIC NECK SYNDROME 1
484 PRESCRIBED OVERDOSE 1
485 PRODUCT ADMINISTRATION INTERRUPTED 1
486 PRODUCT CLOSURE ISSUE 1
487 PRODUCT CONTAMINATION MICROBIAL 1
488 PRODUCT LABEL ISSUE 1
489 PRODUCT LABEL ON WRONG PRODUCT 1
490 PRODUCT PACKAGE ASSOCIATED INJURY 1
491 PRODUCT SOLUBILITY ABNORMAL 1
492 PRODUCT SUBSTITUTION ISSUE 1
493 PRODUCT TASTE ABNORMAL 1
494 PROSTATE CANCER METASTATIC 1
495 PSORIATIC ARTHROPATHY 1
496 PULMONARY HYPERTENSION 1
497 PULMONARY MASS 1
498 PULMONARY PAIN 1
499 QUALITY OF LIFE DECREASED 1
500 RADICULOPATHY 1
501 RASH MACULAR 1
502 RASH MACULO-PAPULAR 1
503 RASH PRURITIC 1
504 RECALLED PRODUCT ADMINISTERED 1
505 RENAL DISORDER 1
506 RENAL FAILURE ACUTE 1
507 RESPIRATORY DISORDER 1
508 RESPIRATORY TRACT INFECTION 1
509 RHABDOMYOLYSIS 1
510 RHONCHI 1
511 ROTATOR CUFF SYNDROME 1
512 SCHIZOAFFECTIVE DISORDER 1
513 SCOLIOSIS 1
514 SENSITIVE SKIN 1
515 SERUM FERRITIN DECREASED 1
516 SHOULDER OPERATION 1
517 SINGLE COMPONENT OF A TWO-COMPONENT PRODUCT ADMINISTERED 1
518 SINUS DISORDER 1
519 SKIN ABRASION 1
520 SKIN GRAFT 1
521 SKIN HAEMORRHAGE 1
522 SKIN ODOUR ABNORMAL 1
523 SKIN ULCER 1
524 SKIN WARM 1
525 SLEEP DEFICIT 1
526 SLEEP DISORDER 1
527 SPINAL DISORDER 1
528 SQUAMOUS CELL CARCINOMA 1
529 STENOSIS 1
530 SURGERY 1
531 SUSPECTED COVID-19 1
532 SWELLING FACE 1
533 SWOLLEN TONGUE 1
534 SYNCOPE 1
535 SYSTEMIC LUPUS ERYTHEMATOSUS 1
536 TEMPOROMANDIBULAR JOINT SYNDROME 1
537 TENDON DISORDER 1
538 TENDON PAIN 1
539 TENDONITIS 1
540 THALAMUS HAEMORRHAGE 1
541 THERAPY PARTIAL RESPONDER 1
542 THIRD DEGREE CHEMICAL BURN OF SKIN 1
543 THROMBOSIS 1
544 TONGUE NEOPLASM MALIGNANT STAGE UNSPECIFIED 1
545 TOOTHACHE 1
546 TRANSIENT ISCHAEMIC ATTACK 1
547 TRAUMATIC HAEMORRHAGE 1
548 TRYPTASE INCREASED 1
549 UNEVALUABLE EVENT 1
550 UNINTENTIONAL USE FOR UNAPPROVED INDICATION 1
551 URINARY INCONTINENCE 1
552 URINE OUTPUT DECREASED 1
553 VARICOSE VEIN 1
554 VENTRICULAR SEPTAL DEFECT 1
555 VERY LOW DENSITY LIPOPROTEIN INCREASED 1
556 VISUAL IMPAIRMENT 1
557 WHEELCHAIR USER 1
558 WHEEZING 1
559 WOUND HAEMORRHAGE 1
560 WOUND INFECTION 1